GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 726 - 750 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▲
IgG Patient 3 4 mild
G58969RU
45
IgG Patient 1 10 moderate
G65889KE
46
IgG Patient 1 22 moderate
G30839DN
46
IgG Patient 1 22 moderate
G68703KI
46
IgM Patient 1 10 moderate
G08520NM
46
IgM Patient 1 10 moderate
G29011JC
46
IgM Patient 1 10 moderate
G76355TG
46
IgM Patient 1 10 moderate
G78074HX
46
IgM Patient 1 10 moderate
G89993FE
46
IgM Patient 1 6 moderate
G21675ZL
46
IgM Patient 1 6 moderate
G51872EK
46
IgM Patient 1 6 moderate
G73271MD
46
IgG Patient 2 15 mild
G25407RZ
46
IgG Patient 2 15 mild
G66937TJ
46
IgG Patient 2 24 mild
G09482NW
46
IgG Patient 2 24 mild
G25407RZ
46
IgG Patient 2 24 mild
G32699RJ
46
IgG Patient 2 24 mild
G63074CQ
46
IgG Patient 2 24 mild
G86566MF
46
IgM Patient 2 24 mild
G00053MO
46
IgM Patient 2 24 mild
G24432YB
46
IgG Patient 2 3 mild
G14844CX
46
IgG Patient 2 3 mild
G29857RC
46
IgM Patient 2 3 mild
G00052MO
46
IgG Patient 3 -180 mild
G02557XE
46

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024